Reproducibility of cardiopulmonary exercise measurements in patients with pulmonary arterial hypertension

被引:60
|
作者
Hansen, JE
Sun, XG
Yasunobu, Y
Garafano, RP
Gates, G
Barst, RJ
Wasserman, K
机构
[1] Harbor UCLA Med Ctr, Res & Educ Inst, Dept Med, Torrance, CA 90509 USA
[2] Columbia Presbyterian Med Ctr, Dept Pediat, New York, NY 10032 USA
关键词
anaerobic threshold; exercise testing; O-2; pulse; peak O-2 uptake; reproducibility; ventilatory efficiency; ventilatory equivalent for CO2;
D O I
10.1378/chest.126.3.816
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Background and objectives: As part of a recent study, cardiopulmonary exercise tests (CPETs) were used to evaluate and follow up patients with pulmonary arterial hypertension (PAR). These patients were more impaired than those in other published series evaluating CPET reproducibility. We used these patient tests to assess patient performance variability and evaluate reading variability. To achieve this end, six independent evaluators graded key CPET measurements in patients with PAH who underwent duplicate CPETs within 3 days of each other. Setting and patients: Over a 15-month period at two tertiary-care teaching hospitals, 42 patients with PAH underwent repeated, paired CPETs using cycle ergometry. Interventions and measurements: Each patient underwent one to six pairs of cycle ergometry tests to maximal tolerance. Each pair of tests was separated by 3 months, with each test in the pair separated by 1 to 3 days. Specific guidelines were given to the independent evaluators for the key measurements assessed from each CPET study: peak O-2 uptake (Vo(2)), peak heart rate, peak O-2 pulse, anaerobic threshold (AT), and end-tidal Po-2, end-tidal Pco(2), and the ventilatory equivalent for CO2 at the AT (VE/VCO2@AT). Results: There were no fatalities or complications occurring among the 242 tests performed on 42 patients. The mean peak Vo(2) was 722 mL/min or 41% of predicted; 34 patients were Weber class C or D. Using the specific guidelines to measure the variability of measurements made by the six independent evaluators, the coefficients of variation were < 2.2% for peak Vo(2), peak heart rate, peak 02 pulse, end-tidal values at the AT, and VE/VCO2@AT, while for the AT, it was 8.5%. There were no significant differences in these measurements between the first and second tests of any pair or between the earlier and later sets of pairs. Conclusions: Using specific guidelines, key CPET measurements can be safely, reliably, and reproducibly assessed even in patients with severe exercise intolerance.
引用
收藏
页码:816 / 824
页数:9
相关论文
共 50 条
  • [1] Cardiopulmonary exercise testing in patients with pulmonary arterial hypertension: An evidence-based review
    Arena, Ross
    Lavie, Carl J.
    Milani, Richard V.
    Myers, Jonathan
    Guazzi, Marco
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2010, 29 (02) : 159 - 173
  • [2] Reproducibility of maximal cardiopulmonary exercise testing for young cystic fibrosis patients
    Saynor, Zoe L.
    Barker, Alan R.
    Oades, Patrick J.
    Williams, Craig A.
    JOURNAL OF CYSTIC FIBROSIS, 2013, 12 (06) : 644 - 650
  • [3] Cardiopulmonary Exercise Testing in Pulmonary Hypertension
    Weatherald, Jason
    Farina, Stefania
    Bruno, Noemi
    Laveneziana, Pierantonio
    ANNALS OF THE AMERICAN THORACIC SOCIETY, 2017, 14 : S84 - S92
  • [4] Evaluating exercise capacity in patients with pulmonary arterial hypertension
    Babu, Abraham Samuel
    Myers, Jonathan
    Arena, Ross
    Maiya, Arun G.
    Padmakumar, Ramachandran
    EXPERT REVIEW OF CARDIOVASCULAR THERAPY, 2013, 11 (06) : 729 - 737
  • [5] Exercise Hemodynamics in the Prognosis of Patients with Pulmonary Arterial Hypertension
    Faure, Morgane
    Valentin, Simon
    Zysman, Maeva
    Sitbon, Olivier
    Peretti, Laura
    Guillaumot, Anne
    Gomez, Emmanuel
    Huttin, Olivier
    Selton-Suty, Christine
    Chabot, Francois
    Chaouat, Ari
    RESPIRATION, 2020, 99 (08) : 678 - 685
  • [6] Cardiopulmonary exercise testing in the assessment of pulmonary hypertension
    Arena, Ross
    Guazzi, Marco
    Myers, Jonathan
    Grinnen, Daniel
    Forman, Daniel E.
    Lavie, Carl J.
    EXPERT REVIEW OF RESPIRATORY MEDICINE, 2011, 5 (02) : 281 - 293
  • [7] Exercise Capacity and Ventilatory Efficiency in Patients With Pulmonary Arterial Hypertension
    Tobita, Kazuki
    Goda, Ayumi
    Teruya, Koji
    Nishida, Yuichiro
    Takeuchi, Kaori
    Kikuchi, Hanako
    Inami, Takumi
    Kohno, Takashi
    Tashiro, Syoichi
    Yamada, Shin
    Satoh, Toru
    Soejima, Kyoko
    JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2023, 12 (11):
  • [8] Cardiopulmonary Exercise Testing as a Tool for Diagnosing Pulmonary Hypertension in Patients with Dilated Cardiomyopathy
    Hirashiki, Akihiro
    Kondo, Takahisa
    Okumura, Takahiro
    Kamimura, Yoshihiro
    Nakano, Yoshihisa
    Fukaya, Kenji
    Sawamura, Akinori
    Morimoto, Ryota
    Adachi, Shiro
    Takeshita, Kyosuke
    Murohara, Toyoaki
    ANNALS OF NONINVASIVE ELECTROCARDIOLOGY, 2016, 21 (03) : 263 - 271
  • [9] Cardiopulmonary exercise test characteristics in patients with chronic obstructive pulmonary disease and associated pulmonary hypertension
    Holverda, Sebastiaan
    Bogaard, Harm J.
    Groepenhoff, H.
    Postmus, Pieter E.
    Boonstra, Anco
    Vonk-Noordegraaf, Anton
    RESPIRATION, 2008, 76 (02) : 160 - 167
  • [10] Response to exercise in patients with pulmonary arterial hypertension treated with combination therapy
    Nishizaki, Mari
    Ogawa, Aiko
    Matsubara, Hiromi
    ERJ OPEN RESEARCH, 2021, 7 (01)